Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Thrombosis and Haemostasis

• Publication date

  2013-09-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH13-04-0354PMID 24067944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelets in thrombosis and hemostasis: old topic with new mechanisms.

  2012cited by this paper
• Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody‐mediated immune suppression and prevention of severe clinical complications in a murine model

  2012cited by this paper
• The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.

  2011influential reference
• Different Toll-Like Receptor Stimuli Have a Profound Impact on Cytokines Required to Break Tolerance and Induce Autoimmunity

  2011influential reference
• Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia.

  2011influential reference
• Tn Glycosylation of the MUC6 Protein Modulates Its Immunogenicity and Promotes the Induction of Th17-biased T Cell Responses*

  2010cited by this paper
• Bernard Soulier syndrome in pregnancy: a systematic review

  2010cited by this paper
• Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy.

  2010influential reference
• The ITP syndrome: pathogenic and clinical diversity.

  2009influential reference
• Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.

  2009cited by this paper
• Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression.

  2009cited by this paper
• A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn

  2008cited by this paper
• Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates.

  2008cited by this paper
• thrombocytopenia: response to intravenous IgG therapy A novel murine model of fetal and neonatal alloimmune

  2008influential reference
• The known unknowns of antigen processing and presentation

  2008cited by this paper
• Immune thrombocytopenic purpura in adults

  2007cited by this paper
• A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia.

  2007cited by this paper
• Differential liver sensitization to Toll‐like receptor pathways in mice with alcoholic fatty liver

  2006cited by this paper
• Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo.

  2006cited by this paper
• Foetal and neonatal alloimmune thrombocytopaenia

  2006cited by this paper
• Maturation of murine bone marrow-derived dendritic cells with poly(I:C) produces altered TLR-9 expression and response to CpG DNA.

  2006cited by this paper
• Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase—deficient mice

  2005cited by this paper
• Prospective epidemiologic study of the outcome and cost‐effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti‐HPA‐1a

  2005cited by this paper
• Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies

  2004cited by this paper
• Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?

  2004cited by this paper
• Neonatal alloimmune thrombocytopenia due to anti-HPA-2b (anti-Koa)

  2003cited by this paper
• Crystal Structure of the Platelet Glycoprotein Ibα N-terminal Domain Reveals an Unmasking Mechanism for Receptor Activation*

  2002cited by this paper
• Platelets in atherothrombosis

  2002cited by this paper
• Protein A immunoadsorption in a pregnant woman with habitual abortion.

  2002cited by this paper
• Microbial Lipopeptides Stimulate Dendritic Cell Maturation Via Toll-Like Receptor 21

  2001cited by this paper
• Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome.

  2000cited by this paper
• Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

  1999cited by this paper
• Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex

  1999cited by this paper
• Antepartum diagnosis of fetal intracranial hemorrhage due to maternal Bernard-Soulier syndrome.

  1999cited by this paper
• Clinical Aspects and Typing of Platelet Alloantigens

  1998cited by this paper
• The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening.

  1998cited by this paper
• Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

  1998cited by this paper
• Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori.

  1998cited by this paper
• Fetal alloimmune thrombocytopenia.

  1997cited by this paper
• Mechanisms Initiating Platelet Thrombus Formation

  1997cited by this paper
• Feto-maternal transfusion in normal pregnancy and during delivery.

  1997cited by this paper
• SEVERE FETOMATERNAL ALLOIMMUNE THROMBOCYTOPENIA PRESENTING WITH FETAL HYDROCEPHALUS

  1996cited by this paper
• Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.

  1996cited by this paper
• Alloimmunization against ly, a Low‐Frequency Antigen on Platelet Glycoprotein Ib/IX as a Cause of Severe Neonatal Alloimmune Thrombocytopenic Purpura

  1995cited by this paper
• Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.

  1995cited by this paper
• Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane.

  1992cited by this paper
• GPIIb-IIIa: the responsive integrin.

  1991cited by this paper
• 348 cases of suspected neonatal alloimmune thrombocytopenia

  1989cited by this paper
• 348 cases of suspected neonatal alloimmune thrombocytopenia.

  1989cited by this paper
• Neonatal Alloimmune Amegakaryocytosis:

  1988cited by this paper
• Neonatal alloimmune amegakaryocytosis. Case report.

  1988cited by this paper

• Maternal and placental galectins: key players in the feto-maternal symbiotic tango

  2025cites this paper
• Advances in Understanding Lipopolysaccharide-Mediated Hepatitis: Mechanisms and Pathological Features

  2025cites this paper
• SARS-CoV-2 RBD and Its Variants Can Induce Platelet Activation and Clearance: Implications for Antibody Therapy and Vaccinations against COVID-19

  2023cites this paper
• Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia.

  2021cites this paper
• Immune-Mediated Cytopenia in the Pediatric Setting

  2020cites this paper
• Updated understanding of platelets in thrombosis and hemostasis: the roles of integrin PSI domains and their potential as therapeutic targets.

  2020cites this paper
• Crosstalk Between Platelets and Microbial Pathogens

  2020influential citation
• Murine models for studying treatment, prevention and pathogenesis of FNAIT.

  2019cites this paper
• Alloimmune Thrombocytopenia

  2019cites this paper
• Platelet physiology and immunology: pathogenesis and treatment of classical and non-classical fetal and neonatal alloimmune thrombocytopenia

  2019cites this paper
• GPIbα is required for platelet-mediated hepatic thrombopoietin generation.

  2018cites this paper
• Fetal and neonatal alloimmune thrombocytopenia: Novel mechanisms of miscarriage learned from placental pathology in animal models

  2018cites this paper
• Plant-based Food Cyanidin-3-Glucoside Modulates Human Platelet Glycoprotein VI Signaling and Inhibits Platelet Activation and Thrombus Formation.

  2017cites this paper
• Current perspectives on fetal and neonatal alloimmune thrombocytopenia – increasing clinical concerns and new treatment opportunities

  2017cites this paper
• Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia

  2017cites this paper
• Fetal and neonatal alloimmune thrombocytopenia.

  2016cites this paper
• Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond

  2016cites this paper
• Platelets, immune-mediated thrombocytopenias, and fetal hemorrhage.

  2016cites this paper
• The Journal of Clinical Investigation

  2016cites this paper
• Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia

  2015influential citation
• Apolipoprotein A-IV: Novel αIIbβ3 Integrin Ligand and Endogenous Thrombotic Inhibitor

  2015influential citation
• PLATELETS AND THROMBOPOIESIS CD 8 1 T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia

  2015cites this paper
• Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia

  2015cites this paper
• Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention

  2015cites this paper
• Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.

  2015cites this paper
• CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.

  2015cites this paper